We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAD
1976
DELISTED
Rite Aid Corporation
RAD
| $1.72M | ﹤0.01% |
83,916
-12,074
| -13% | -$262K |
|
1977
Travere Therapeutics
TVTX
$5.78B
| $1.72M | ﹤0.01% |
68,669
-2,409
| -3% | -$66.6K |
|
1978
Sprout Social
SPT
$621M
| $1.71M | ﹤0.01% |
29,636
-1,980
| -6% | -$124K |
|
|
EVRI
1979
DELISTED
Everi Holdings
EVRI
| $1.71M | ﹤0.01% |
120,941
-5,342
| -4% | -$76K |
|
1980
Health Catalyst
HCAT
$128M
| $1.71M | ﹤0.01% |
36,483
-3,837
| -10% | -$186K |
|
1981
Magnolia Oil & Gas
MGY
$5.94B
| $1.71M | ﹤0.01% |
148,590
-14,131
| -9% | -$147K |
|
1982
Heron Therapeutics
HRTX
$92.9M
| $1.7M | ﹤0.01% |
104,876
-10,162
| -9% | -$181K |
|
1983
Liquidity Services
LQDT
$1.32B
| $1.7M | ﹤0.01% |
91,510
+762
| +0.8% | +$13.8K |
|
1984
iHeartMedia
IHRT
$583M
| $1.7M | ﹤0.01% |
93,520
-3,359
| -3% | -$50.7K |
|
1985
iShares S&P 500 Value ETF
IVE
$49.8B
| $1.69M | ﹤0.01% |
11,958
| – | – |
|
1986
Stock Yards Bancorp
SYBT
$2.6B
| $1.69M | ﹤0.01% |
33,042
-10,900
| -25% | -$523K |
|
1987
Phibro Animal Health
PAHC
$1.39B
| $1.68M | ﹤0.01% |
68,932
+1,776
| +3% | +$40.1K |
|
1988
BRC Group Holdings
RILY
$289M
| $1.68M | ﹤0.01% |
29,816
-2,143
| -7% | -$116K |
|
1989
Atara Biotherapeutics
ATRA
$76.1M
| $1.67M | ﹤0.01% |
4,645
-257
| -5% | -$114K |
|
|
FOCS
1990
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $1.64M | ﹤0.01% |
39,512
+1,461
| +4% | +$70.7K |
|
|
SPPI
1991
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.64M | ﹤0.01% |
503,919
+11,440
| +2% | +$41K |
|
1992
Arlo Technologies
ARLO
$1.65B
| $1.64M | ﹤0.01% |
260,817
+6,357
| +2% | +$49.8K |
|
1993
Metallus
MTUS
$898M
| $1.64M | ﹤0.01% |
139,176
-4,286
| -3% | -$32K |
|
1994
Golar LNG
GLNG
$5.13B
| $1.63M | ﹤0.01% |
159,715
-4,773
| -3% | -$53.6K |
|
|
RDUS
1995
DELISTED
Radius Recycling
RDUS
| $1.63M | ﹤0.01% |
38,922
-3,650
| -9% | -$133K |
|
1996
National Healthcare
NHC
$3.38B
| $1.62M | ﹤0.01% |
20,800
-1,231
| -6% | -$87.1K |
|
1997
The RMR Group
RMR
$332M
| $1.62M | ﹤0.01% |
39,702
+21,340
| +116% | +$842K |
|
1998
REX American Resources
REX
$1.41B
| $1.62M | ﹤0.01% |
115,350
-108
| -0.1% | -$1.66K |
|
|
BFS
1999
Saul Centers
BFS
$841M
| $1.62M | ﹤0.01% |
40,291
-19,686
| -33% | -$699K |
|
|
VVNT
2000
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $1.62M | ﹤0.01% |
112,858
-3,775
| -3% | -$68.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.